Key Factor Supporting Lentiviral Vector Market Development in 2025: Lentiviral Vectors Market Driven By Rising Prevalence Of Chronic Diseases

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Lentiviral Vector Market Size By 2025?
The size of the lentiviral vector market has expanded significantly in the past few years. Projections show an increase from $14.37 billion in 2024 to $16.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.7%. Factors contributing to this growth during the historic period include the increasing prevalence of genetic disorders, growing demand for gene delivery, expansion of biotechnology and pharmaceutical sectors, investments in clinical trials and regulatory approvals.

How Big Is the Lentiviral Vector Market Size Expected to Grow by 2029?
The size of the lentiviral vector market is predicted to expand swiftly over the approaching years, estimated to reach "$27.71 billion by 2029, with a compound annual growth rate (CAGR) of 13.9%. This anticipated growth during the forecast period can be associated with the rise in personalized medicine, advancements in gene editing, increased demand for therapy concerning rare diseases, the adoption of lentiviral vectors, resources put into genomic medicine, and a focus on the scalability of production. Major trends expected during this forecast period include the broadening of research and development, the use in CAR-T cell therapy, the creation of next-generation vectors, vaccine development pursuits, and advancements in production technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lentiviral-vector-global-market-report

Which Key Market Drivers Powering Lentiviral Vector Market Expansion and Growth?
The lentiviral vectors market is projected to witness growth due to an increase in chronic illnesses. Chronic illnesses are persistent, long-term medical conditions that usually develop over a period of time, often enduring for several years or even a lifetime. Factors such as aging populations, unhealthy lifestyles, urbanization, and environmental conditions are adding to the rise of these diseases. Technologically advanced and highly useful lentiviral vectors are crucial in creating vaccines and treatment methods for chronic illnesses, thus addressing unmet medical needs and improving patient outcomes. As highlighted by the British Heart Foundation, a cardiovascular research charity in the UK, in September 2024, around 7.6 million individuals, approximately 4 million men, and 3.6 million women in the UK live with cardiovascular diseases. These ailments are the cause of about 27% of all recorded deaths in the UK, equating to more than 170,000 fatalities each year, or roughly 480 fatalities daily, approximately one death every three minutes. Such significant health concerns are contributing to the growth of the lentiviral vectors market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14742&type=smp

What Are the Key Trends Driving Lentiviral Vector Market Growth?
Major firms in the lentiviral vectors market are striving to enhance the efficacy and reliability of lentivirus vector production for cell-based immuno-oncology therapies by devising LV vector manufacturing platforms, like LentiSure. Designed to boost efficiency and resilience in vector creation, LentiSure is utilized in the production of lentiviral vectors for cell-based immuno-oncology treatments. In May 2023, for example, Yposkesi sk pharmteco, a viral vector manufacturer based in France, introduced LentiSure. This sophisticated platform was developed to improve the production of LV vectors, with the goal of enhancing the durability and efficacy of lentivirus production. With its ability to fulfil the escalating demand for robust and economically viable viral-vector manufacturing technologies in cell and gene therapies, it provides consistent product quality. With average titers at cell culture harvest at 10e7 IG/mL bioreactor volume, it guarantees improved productivity and successful outcomes for those developing cell therapies.

What Are the Emerging Segments in the Lentiviral Vector Market?
The lentiviral vector market covered in this report is segmented -

1) By Product Type: Kits, Reagents And Consumables
2) By Indication: Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications
3) By End User: Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes

Subsegments:
1) By Kits: Lentiviral Transduction Kits, Lentiviral Packaging Kits, Lentiviral Vector Production Kits
2) By Reagents and Consumables: Lentiviral Packaging Reagents, Lentiviral Vector Concentration Reagents, Transfection Reagents for Lentiviral Vectors

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14742&type=smp

Who Are the Global Leaders in the Lentiviral Vector Market?
Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi

Which are the Top Profitable Regional Markets for the Lentiviral Vector Industry?
North America was the largest region in the lentiviral vector market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14742

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.